| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $144.1M | +26.1% |
| SG&A Expense | $48.8M | -2.1% |
| Operating Income | -$192.9M | -17.5% |
| Pre-tax Income | -$167.5M | -24.1% |
| Income Tax | $925K | -9.1% |
| Net Income | -$168.4M | -23.9% |
| EPS (Basic) | -$2.00 | -22.7% |
| EPS (Diluted) | -$2.00 | -22.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.7M | -55.0% |
| Current Assets | $462.4M | -21.7% |
| Total Assets | $464.7M | -21.9% |
| Current Liabilities | $18.6M | -42.5% |
| Total Liabilities | $25.8M | -35.1% |
| Stockholders' Equity | $438.9M | -21.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$135.5M | -58.7% |
| Investing Cash Flow | $56.1M | +39.2% |
| Financing Cash Flow | $267K | +3.9% |